相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
Elizabeth Thiele et al.
EPILEPSIA (2019)
Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex
Peter E. Davis et al.
EPILEPSIA (2019)
Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: A Long-Term, Prospective Trial
Sergiusz Jozwiak et al.
PEDIATRIC NEUROLOGY (2019)
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Orrin Devinsky et al.
EPILEPSIA (2019)
Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
Rima Nabbout et al.
EPILEPSIA OPEN (2019)
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
Darcy A. Krueger et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
Paolo Curatolo et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex
Emma A. van der Poest Clement et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex
Shaun A. Hussain et al.
EPILEPSY RESEARCH (2018)
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial
David N. Franz et al.
NEUROLOGY-CLINICAL PRACTICE (2018)
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial
Paolo Curatolo et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex
Fiona M. Baumer et al.
CEREBRAL CORTEX (2018)
Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy
Michele C. Jackson et al.
EPILEPSIA (2017)
Influence of seizures on early development in tuberous sclerosis complex
Jamie K. Capal et al.
EPILEPSY & BEHAVIOR (2017)
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial
FinbarJ K. O'Callaghan et al.
LANCET NEUROLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide
Mark Davies et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants
Peter E. Davis et al.
PEDIATRICS (2017)
Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome
Carl E. Stafstrom et al.
FRONTIERS IN NEUROLOGY (2017)
Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders
Darcy A. Krueger et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
Anna Jeong et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
Evan J. Hess et al.
EPILEPSIA (2016)
Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry
John M. Pellock et al.
EPILEPSY & BEHAVIOR (2016)
Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy
Anna Jeong et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Jacqueline A. French et al.
LANCET (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial
Iris E. Overwater et al.
NEUROLOGY (2016)
Long-term treatment of epilepsy with everolimus in tuberous sclerosis
Darcy A. Krueger et al.
NEUROLOGY (2016)
Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study
Sharon Samueli et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants
Joyce Y. Wu et al.
PEDIATRIC NEUROLOGY (2016)
Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy
Anna Jeong et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs
Iris E. Overwater et al.
EPILEPSIA (2015)
Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex
Alexandra L. Geffrey et al.
EPILEPSY RESEARCH (2015)
Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy
Paolo Curatolo
PEDIATRIC NEUROLOGY (2015)
Perimetry in Young and Neurologically Impaired Children The Behavioral Visual Field (BEFIE) Screening Test Revisited
Yvonne Koenraads et al.
JAMA OPHTHALMOLOGY (2015)
Severity of manifestations in tuberous sclerosis complex in relation to genotype
Sanjeev V. Kothare et al.
EPILEPSIA (2014)
Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex
Daniel Friedman et al.
EPILEPSY & BEHAVIOR (2013)
Epileptic spasms in tuberous sclerosis complex
David T. Hsieh et al.
EPILEPSY RESEARCH (2013)
Clobazam therapy of refractory epilepsy in tuberous sclerosis complex
Melanie Jennesson et al.
EPILEPSY RESEARCH (2013)
Vigabatrin and Mental Retardation in Tuberous Sclerosis: Infantile Spasms Versus Focal Seizures
Mi-Sun Yum et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler et al.
LANCET (2013)
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Darcy A. Krueger et al.
PEDIATRIC NEUROLOGY (2013)
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Hope Northrup et al.
PEDIATRIC NEUROLOGY (2013)
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
Raffaella Cusmai et al.
EPILEPSY & BEHAVIOR (2011)
Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex
Sergiusz Jozwiak et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2011)
The natural history of epilepsy in tuberous sclerosis complex
Catherine J. Chu-Shore et al.
EPILEPSIA (2010)
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
Roberta Bombardieri et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2010)
Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex
J. Y. Wu et al.
NEUROLOGY (2010)
Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin Final Results from an Open-Label, Observational, Multicentre Study
John M. Wild et al.
CNS DRUGS (2009)
Cerebral MRI abnormalities associated with vigabatrin therapy
Phillip L. Pearl et al.
EPILEPSIA (2009)
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
Ling-Hui Zeng et al.
ANNALS OF NEUROLOGY (2008)
Transient magnetic resonance diffusion abnormalities in West syndrome: the radiological expression of non-convulsive status epilepticus?
Isabelle Desguerre et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2008)
Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile
Susana E. Camposano et al.
EPILEPSIA (2008)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epilepsy surgery in young children with tuberous sclerosis: Results of a novel approach
HL Weiner et al.
PEDIATRICS (2006)
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: A retrospective open-label trial
James J. Collins et al.
JOURNAL OF CHILD NEUROLOGY (2006)
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial
AL Lux et al.
LANCET NEUROLOGY (2005)
Randomized trial of vigabatrin in patients with infantile spasms
RD Elterman et al.
NEUROLOGY (2001)
Lamotrigine therapy of epilepsy in tuberous sclerosis
DN Franz et al.
EPILEPSIA (2001)
Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients
I Jambaqué et al.
EPILEPSY RESEARCH (2000)
分享论文
